1. Home
  2. THRY vs GHRS Comparison

THRY vs GHRS Comparison

Compare THRY & GHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • THRY
  • GHRS
  • Stock Information
  • Founded
  • THRY 2012
  • GHRS 2018
  • Country
  • THRY United States
  • GHRS Ireland
  • Employees
  • THRY N/A
  • GHRS N/A
  • Industry
  • THRY Industrial Machinery/Components
  • GHRS Biotechnology: Pharmaceutical Preparations
  • Sector
  • THRY Industrials
  • GHRS Health Care
  • Exchange
  • THRY Nasdaq
  • GHRS Nasdaq
  • Market Cap
  • THRY 587.3M
  • GHRS 583.1M
  • IPO Year
  • THRY 2020
  • GHRS 2021
  • Fundamental
  • Price
  • THRY $13.75
  • GHRS $10.60
  • Analyst Decision
  • THRY Strong Buy
  • GHRS Strong Buy
  • Analyst Count
  • THRY 5
  • GHRS 8
  • Target Price
  • THRY $21.40
  • GHRS $30.63
  • AVG Volume (30 Days)
  • THRY 699.4K
  • GHRS 146.4K
  • Earning Date
  • THRY 05-01-2025
  • GHRS 05-08-2025
  • Dividend Yield
  • THRY N/A
  • GHRS N/A
  • EPS Growth
  • THRY N/A
  • GHRS N/A
  • EPS
  • THRY N/A
  • GHRS N/A
  • Revenue
  • THRY $771,903,000.00
  • GHRS N/A
  • Revenue This Year
  • THRY N/A
  • GHRS N/A
  • Revenue Next Year
  • THRY N/A
  • GHRS N/A
  • P/E Ratio
  • THRY N/A
  • GHRS N/A
  • Revenue Growth
  • THRY N/A
  • GHRS N/A
  • 52 Week Low
  • THRY $10.03
  • GHRS $6.00
  • 52 Week High
  • THRY $26.42
  • GHRS $20.50
  • Technical
  • Relative Strength Index (RSI)
  • THRY 55.04
  • GHRS 59.36
  • Support Level
  • THRY $13.08
  • GHRS $9.81
  • Resistance Level
  • THRY $14.15
  • GHRS $11.50
  • Average True Range (ATR)
  • THRY 0.83
  • GHRS 0.72
  • MACD
  • THRY 0.21
  • GHRS 0.23
  • Stochastic Oscillator
  • THRY 84.31
  • GHRS 89.60

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

About GHRS GH Research PLC

GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.

Share on Social Networks: